For patients with CKD and T2D, combination finerenone plus empagliflozin leads to a greater reduction in the urinary albumin-to-creatinine ratio than either agent alone.

"Omega-3 fatty acids have been known for their cardioprotective effects and they have broad anti-inflammatory properties, ...